Virginia Regulatory Town Hall
Agency
Department of Health Professions
Board
Board of Pharmacy
chapter
Regulations Governing the Practice of Pharmacy [18 VAC 110 ‑ 20]
Action is Exempt from Article 2 of the Administrative Process Act
Action:
De-scheduling of drug to conform to DEA
Action 5667
 
General Information
Action Summary As specified in § 54.1-3443 (E), the Board has acted to de-schedule a drug (epidiolex) in the Virginia Drug Control Act in accordance with actions of the U. S. Drug Enforcement Act (DEA) “after the expiration of 30 days from publication in the Federal Register of a final or interim final order or rule.”
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: 54.1-3443 (E) and 2.2-4006
RIS Project Yes  [6584]
New Periodic Review This action will not be used to conduct a new periodic review.
 
Stages
Stages associated with this regulatory action.
Stage ID Stage Type Status
9168 Final Stage complete. This regulation became effective on 02/17/2021.
 
Contact Information
Name / Title: Caroline Juran, RPh  / Executive Director
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
Email Address: caroline.juran@dhp.virginia.gov
Phone: (804)367-4456    FAX: (804)527-4472    TDD: ()-

This person is the primary contact for this chapter.